STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

AMRX AMNEAL PHARMACEUTICALS StockScouter® Report

5

StockScouter® Score

AMNEAL PHARMACEUTICALS, a small cap value company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • The 50-day moving average for AMRX is above its 200-day moving average. Positive

 

Concerns

  • One or more analysts has significantly decreased quarterly earnings estimates for AMRX. Negative
  • Short-term relative price momentum exhibits moderate weakness. Neutral/Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, value stocks will be out of favor, and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 80% done.
Progress: 80% done.
Low
High

Core Model Grades

B
N/A
C
C

Previous Ratings

7
5
3